Taurx Therapeutics Management Ltd.

General information

Name:

Taurx Therapeutics Management Limited.

Office Address:

395 King Street AB24 5RP Aberdeen

Number: SC531195

Incorporation date: 2016-03-31

End of financial year: 30 June

Category: Private Limited Company

Status: Active

Description

Data updated on:

Taurx Therapeutics Management is a company registered at AB24 5RP Aberdeen at 395 King Street. This enterprise has been operating since 2016 and is registered under the identification number SC531195. This enterprise has been on the British market for eight years now and company last known status is active. This enterprise's SIC and NACE codes are 72110 meaning Research and experimental development on biotechnology. Its latest annual accounts detail the period up to 2022/06/30 and the latest annual confirmation statement was released on 2023/03/30.

Glenn C., John S. and Claude W. are registered as the company's directors and have been working on the company success since January 2022.

Financial data based on annual reports

Company staff

Glenn C.

Role: Director

Appointed: 31 January 2022

Latest update: 4 May 2024

John S.

Role: Director

Appointed: 31 January 2022

Latest update: 4 May 2024

Claude W.

Role: Director

Appointed: 31 March 2016

Latest update: 4 May 2024

People with significant control

Taurx Therapeutics Limited
Address: #21-04 Shenton House 3 Shenton Way, Singapore 068805, 068805, Singapore
Legal authority Companies Act (Singaporean)
Legal form Limited Company
Notified on 17 May 2018
Ceased on 17 May 2018
Nature of control:
over 3/4 of shares
Taurx Therapeutics Ltd.
Address: #21-04 Shenton House Shenton Way, Singapore, 068805, Singapore
Legal authority Singaporean
Legal form Limited Company
Country registered Republic Of Singapore
Place registered Register Of Companies
Registration number 200205235h
Notified on 6 April 2017
Ceased on 16 May 2018
Nature of control:
over 3/4 of shares
3/4 to full of voting rights
right to manage directors

Accounts Documents

Account next due date 31 March 2024
Account last made up date 30 June 2022
Confirmation statement next due date 13 April 2024
Confirmation statement last made up date 30 March 2023
Annual Accounts
Start Date For Period Covered By Report 2016-03-31
Annual Accounts
Start Date For Period Covered By Report 2017-07-01
End Date For Period Covered By Report 2018-06-30
Annual Accounts
Start Date For Period Covered By Report 2018-07-01
End Date For Period Covered By Report 2019-06-30
Annual Accounts
Start Date For Period Covered By Report 2019-07-01
End Date For Period Covered By Report 2020-06-30
Annual Accounts
Start Date For Period Covered By Report 2020-07-01
End Date For Period Covered By Report 2021-06-30
Annual Accounts
Start Date For Period Covered By Report 2021-07-01
End Date For Period Covered By Report 2022-06-30
Annual Accounts
Start Date For Period Covered By Report 2022-07-01
End Date For Period Covered By Report 2023-06-30
Annual Accounts 18 January 2018
End Date For Period Covered By Report 2017-06-30
Date Approval Accounts 18 January 2018

Company filings

Filing category

Hide filing type
Accounts Address Confirmation statement Incorporation Officers Persons with significant control Resolution
Free Download
Confirmation statement with no updates March 30, 2024 (CS01)
filed on: 12th, April 2024
confirmation statement
Free Download Download filing (3 pages)

Search other companies

Services (by SIC Code)

  • 72110 : Research and experimental development on biotechnology
8
Company Age

Similar companies nearby

Closest companies